Testing QLS1410 for people with hard-to-control high blood pressure
Part of Heart & circulation clinical trials.
This trial is testing an experimental drug, QLS1410, to see if it can lower blood pressure in people whose blood pressure is still high even after taking two or more medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- Your average sitting systolic blood pressure is 140 mmHg or higher.
- You have been taking at least two blood pressure pills (including a water pill) at the highest dose you can handle for at least 4 weeks.
- Or you have been taking at least three blood pressure pills (including a water pill) at the highest dose you can handle for at least 4 weeks.
- Your blood pressure is not extremely high (below 180 mmHg systolic and 110 mmHg diastolic).
- Your kidneys work well enough (eGFR is 45 or higher) and your potassium level is between 3.5 and 5.0 mmol/L.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called SPC1001 Low to see if it can safely lower blood pressure in people with essential hypertension (high blood pressure with no known cause). If you are between 19 and 75 years old and have mild to moderate high blood pressure, this study might be an option.
This is a continuation study for people who completed a previous QCZ484 trial and tolerated it well. Researchers will monitor how safe and effective the medication remains with longer-term use for managing high blood pressure.
This early-stage study tests a new investigational drug called QLS1410 in healthy adults and people with mild high blood pressure. The goal is to see how the drug works and if it is safe.
This study checks if taking the experimental drug with food changes how it works in the body. It helps decide the best way to take the drug in future studies.
This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.
This study tests a new drug called QLS1410 for people with primary aldosteronism, a condition that causes high blood pressure due to too much aldosterone. The drug aims to lower blood pressure and improve health, potentially offering a new treatment option.
Hear when a new Hypertension (HTN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.